Chemistry:D-Deprenyl
 | |
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C13H17N |
| Molar mass | 187.286 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
  (what is this?) (verify) | |
d-Deprenyl, also known as or dextro-N-propargyl-N-methylamphetamine, is an MAO-B inhibitor that metabolizes into d-amphetamine and d-methamphetamine and is therefore also a norepinephrine–dopamine releasing agent.[1][2][3][4][5] It is the opposite enantiomer of l-deprenyl (selegiline).
l-Deprenyl, also an MAO-B inhibitor, metabolizes to l-amphetamine and l-methamphetamine, which are both norepinephrine releasing agents. In contrast, d-deprenyl additionally has dopaminergic effects and has been found to be reinforcing in scientific research, whereas l-deprenyl is not known to have any appreciable psychological reinforcement.[6][7]
In addition to its actions as an MAO-B inhibitor and NDRA, d-deprenyl has been found to bind with high affinity to the σ1 receptor (Ki = 79 nM) similarly to various other amphetamine derivatives.[8][9] Its l-isomer, selegiline, binds with 3.5-fold lower affinity in comparison.[8][9]
See also
References
- ↑ "The effect of L-deprenyl, D-deprenyl and MDL72974 on mitochondrial respiration: a possible mechanism leading to an adaptive increase in superoxide dismutase activity". Brain Research. Molecular Brain Research 49 (1–2): 127–136. October 1997. doi:10.1016/S0169-328X(97)00135-6. PMID 9387872.
- ↑ "L-Deprenyl reverses age-associated decline in splenic norepinephrine, interleukin-2 and interferon-γ production in old female F344 rats". Neuroimmunomodulation 20 (2): 72–78. January 2013. doi:10.1159/000345043. PMID 23207416.
- ↑ "D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity". Synapse 50 (1): 7–13. October 2003. doi:10.1002/syn.10239. PMID 12872288.
- ↑ "(-)-D-Deprenyl attenuates apoptosis in experimental brain ischaemia". European Journal of Pharmacology 430 (2–3): 235–241. November 2001. doi:10.1016/S0014-2999(01)01375-9. PMID 11711036.
- ↑ "Evaluation of the stereoisomers of deprenyl for amphetamine-like discriminative stimulus effects in rats". The Journal of Pharmacology and Experimental Therapeutics 265 (1): 1–6. April 1993. PMID 8473997. http://jpet.aspetjournals.org/content/265/1/1.abstract.
- ↑ "A comparison of drug-seeking behavior maintained by D-amphetamine, L-deprenyl (selegiline), and D-deprenyl under a second-order schedule in squirrel monkeys". Psychopharmacology 183 (4): 413–421. January 2006. doi:10.1007/s00213-005-0200-7. PMID 16292593.
- ↑ "Intravenous self-administration studies with l-deprenyl (selegiline) in monkeys". Clinical Pharmacology and Therapeutics 56 (6 Pt 2): 774–780. December 1994. doi:10.1038/clpt.1994.208. PMID 7995020.
- ↑ 8.0 8.1 Sigma Receptors. Academic Press. 1994. p. 84. ISBN 978-0-12-376350-1. https://books.google.com/books?id=ndRqAAAAMAAJ.
- ↑ 9.0 9.1 Acetylcholine, Sigma Receptors, CCK and Eicosanoids, Neurotoxins. Taylor & Francis. January 1993. pp. 124–. ISBN 978-0-7484-0063-8. https://books.google.com/books?id=0xmt5kSpJEcC&pg=PA124.
 |  |
